In the context of Alzheimer’s disease, this refined view suggests that impaired redox signaling—rather than simply ROS overproduction—contributes to amyloid-β aggregation, tau hyperphosphorylation, mitochondrial dysfunction, and neuroinflammation. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.